30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

Smith & Nephew Completes Osiris Acquisition -

Smith & Nephew (SNN) completed its acquisition of Osiris Therapeutics, provider of regenerative medicine products including skin, bone graft and articular cartilage substitutes. Osiris is now an indirect wholly-owned SNN subsidiary. The acquisition is expected to accelerate growth from SNN's Advanced Wound Management segment. As previously noted, Osiris also brings BIO4® viable bone matrix, an alternative to autograft, and Cartiform® cryopreserved viable osteochondral allograft for articular cartilage repair. (Smith & Nephew, 4/17/19)